based inhibitors of xanthine oxidase is described. After a high-throughput screening campaign, an NMR based counterscreen was used to distinguish actives, which interact with XO in a reversible manner, from assay artefacts. This approach identified pyrimidone 1 as a reversible and competitiveinhibitor with good lead-like properties. A hit to lead campaign gave compound 41, a nanomolar inhibitor of hXO
Pyrimidinones. 3. N-Substituted 6-phenylpyrimidinones and pyrimidinediones with diuretic/hypotensive and antiinflammatory activity
作者:Harvey I. Skulnick、James H. Ludens、Michael G. Wendling、E. Myles Glenn、Norman A. Rohloff、Robert J. Smith、Wendell Wierenga
DOI:10.1021/jm00158a030
日期:1986.8
In an extensive analysis of the antiviral and interferon-induction structure-activity relationship of 6-arylpyrimidinones we found that modifications at positions 1-4 of the pyrimidine ring resulted in a loss of activity. However, we uncovered interesting hypotensive and antiinflammatory activity with a series of N-substituted analogues, the results of which we report herein.
SKULNICK, K. I.;WIERENGA, W., HETEROCYCLES, 1985, 23, N 7, 1685-1689